Browsing by Subject "424/184.1"

Now showing items 1-5 of 5

    • Immunoprotective Recombinant Antigen from Anaplasma Marginale, Vaccine Compositions and Methods of Use 

      Fuente, Jose de la; Kocan, Katherine M.; Garcia-Garcia, Jose Carlos; Blouin, Edmour F.; Board of Regents/Oklahoma State University and the A & M Colleges (U.S. Patent and Trademark Office, 2005-09-06)
      Vaccines and methods useful to induce an immune response which is protective to reduce the severity or prevent infection by ehrlichial parasites of the species Anaplasma marginale utilizing recombinant MSP1a surface protein ...

    • M. Haemolytica Outer Membrane Protein P1pe as a Vaccine or Vaccine Component Against Shipping Fever 

      Confer, Anthony W.; Ayalew, Sahlu; Murphy, George L.; Pandher, Karamjeet; Board of Regents/Oklahoma State University and the A & M Colleges (U.S. Patent and Trademark Office, 2006-12-05)
      Vaccines and methods against M. haemolytica infections in cattle. The vaccine compositions include a recombinant outer membrane protein of M. haemolytica designated PlpE and/or subunits thereof, alone or in combination ...

    • Mannheimia Haemolytica Chimeric Outer Membrane Protein Plpe and Leukotoxin Epitopes as a Vaccine or Vaccine Component Against Shipping Fever 

      Ayalew, Sahlu; Confer, Anthony W.; Board of Regents/Oklahoma State University and the A & M Colleges (U.S. Patent and Trademark Office, 2010-09-14)
      Vaccine preparations for the prevention and treatment of bovine respiratory disease (BRD) and, in particular, its most severe form, termed "shipping fever", are provided. The preparations comprise chimeric proteins comprising ...

    • Method for Protecting a Mammalian Host Against Infection by Brucella 

      Enright, Frederick M.; Winter, Alexander J.; Schurig, Gerhardt G.; Wyckoff, John H., III; Louisiana State University (Baton Rouge, La.). Board of Supervisors; Virginia Polytechnic Institute and State University; Board of Regents/Oklahoma State University and the A & M Colleges; Cornell Research Foundation (U.S. Patent and Trademark Office, 2001-07-24)
      Vaccines against facultative intracellular pathogens are disclosed. A host is vaccinated with non-viable but metabolically active agents. The non-viable agents produce immunogenic components that elicit protective host ...

    • Recombinant Antigen Msp1a from Anaplasma Marginale to Reduce Infections in Ticks, Vaccine Compositions and Methods of Use 

      Fuente, Jose de la; Kocan, Katherine M.; Garcia-Garcia, Jose Carlos; Blouin, Edmour F.; Board of Regents/Oklahoma State University and the A & M Colleges (U.S. Patent and Trademark Office, 2005-12-27)
      Vaccines and methods for inducing an immune response in a ruminant. The vaccine composition including pathogen and tick-derived antigens and a carrier or diluent. The method for inducing an immune response in a ruminate ...